Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HUGroup Holdings ( (JP:4544) ) has shared an announcement.
H.U. Group Holdings has revised its full-year consolidated earnings forecast for the fiscal year ending March 31, 2026, trimming expected net sales to ¥250 billion and lowering projections for operating and ordinary profit. The changes reflect the partial divestment of Care’x Inc., which shifted from a consolidated subsidiary to an equity-method affiliate, pressuring reported sales.
Operating profit is now forecast at ¥6 billion, down 25% from the earlier outlook, as margins in the IVD business lag due to an unfavorable sales mix in existing CDMO products amid changing global market conditions. Fixed-cost reduction efforts in the LTS business have also underperformed, although profit attributable to owners of parent and the planned year-end dividend of ¥63 per share remain unchanged, signaling a commitment to shareholder returns despite weaker earnings momentum.
The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3229.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.
More about HUGroup Holdings
H.U. Group Holdings, Inc. is a Japan-based healthcare company listed on the Tokyo Stock Exchange Prime Market, active in areas such as in vitro diagnostics (IVD) and related services. Its portfolio includes an IVD business and an LTS business, and it also engages in contract development and manufacturing (CDMO) activities aligned with global healthcare and diagnostics markets.
YTD Price Performance: -5.00%
Average Trading Volume: 227,260
Technical Sentiment Signal: Buy
Current Market Cap: Yen183.5B
See more data about 4544 stock on TipRanks’ Stock Analysis page.